Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-18
2006-07-18
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S238800, C514S248000, C514S256000, C514S258100, C514S262100, C514S310000, C514S311000, C514S312000, C514S328000, C514S331000, C514S346000, C514S357000, C514S359000, C514S364000, C514S366000, C514S367000, C514S370000, C514S380000, C514S406000, C514S411000, C514S416000, C514S424000, C514S427000, C514S428000, C514S430000, C514S438000, C514S443000, C514S449000, C514S452000, C514S456000, C514S459000, C514S467000, C514S471000, C514S568000, C514S633000, C514S637000
Reexamination Certificate
active
07078400
ABSTRACT:
The present invention relates to an inhibitor for production of 20-hydroxyeicosatetraenoic acid, comprising, as an effective ingredient, specific hydroxyformamidine derivatives or pharmaceutically-acceptable salts thereof. The inhibitors according to the present invention are useful as therapeutic agents for kidney diseases, cerebrovascular diseases, or circulatory diseases.In addition, the present invention also provides novel hydroxyformamidine derivatives or pharmaceutically-acceptable salts thereof.
REFERENCES:
patent: 4237168 (1980-12-01), Reifschneider
patent: 4465841 (1984-08-01), Cereda et al.
patent: 5238964 (1993-08-01), Kikuchi et al.
patent: 2543179 (1976-04-01), None
patent: 27 17 437 (1978-10-01), None
patent: 53-132529 (1978-11-01), None
patent: 0 132 881 (1985-02-01), None
patent: WO 99/43310 (1999-09-01), None
Zinner et al,Chem.-Ztg., 98(3):159 (1974), Abstract.
Hussein et al,Bull. Coll. Sci. Univ. Baghdad, 14:79-87 (1973), Abstract.
Hayakawa et al,J. Pesticide Sci., 17(1):17-25 (1992).
Alonso-Galicia et al,Hypertension, 29(1):320-325 (1997).
Amada Hideaki
Ishii Takaaki
Kobayashi Yuko
Miyata Noriyuki
Sato Masakazu
Kifle Bruck
Taisho Pharmaceutical Co. Ltd.
LandOfFree
20-HETE synthase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 20-HETE synthase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 20-HETE synthase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3532439